Ljubljana stock exchange indices start week up
Zagreb bourse equity indices stagnate
Romanian stock indices start week mostly in the green, BVB shines
Bosnia's building permits up 28.7% y/y in Aug
Albanian gov’t officials convicted in incinerator corruption case
Nov 24, 2009 19:36 EEST
SOFIA (Bulgaria), November 24 (SeeNews) – Bulgaria's pharmaceuticals market will reach $1.275 billion (853 million euro) by 2014, local media reported on Tuesday.
“The pharmaceutical market in Bulgaria is currently estimated at $849 million or $113 per capita and we expect it to grow by an annual 8.5%," the manager for Bulgaria of German drug and chemicals company Bayer, Renato Keller, told local news daily Pari (www.pari.bg) in an interview, quoting data of consulting company Espicom Business Intelligence.
“The Bulgarian drug market has a great potential. The market is positively influenced not only by the fact that almost 18% of the Bulgarian population is over 65, but also because people are more and more aware of health issues and are interested in different ways of disease prevention [...]," Keller also said.
Germany accounts for the biggest share of drug imports to Bulgaria, a country of 7.6 million people. As many as 78% of the pharmaceutical products on the Bulgarian market are imported, the local Bayer executive said.
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. The company employs more than 108,000 people worldwide.
You have run out of free articles this month.
Sign up in for
and get two (2) free articles more per month or sign up for
and get unlimited access.
Browse our free newsletter options